Enhanced susceptibility to chemically induced colitis caused by excessive endosomal TLR signaling in LRBA-deficient mice.
Kuan-Wen WangXiaoming ZhanWilliam McAlpineZhao ZhangJin Huk ChoiHexin ShiTakuma MisawaTao YueDuanwu ZhangYing WangSara LudwigJamie RussellMiao TangXiaohong LiAnne R MurrayEva Marie Y MorescoEmre E TurerBruce A BeutlerPublished in: Proceedings of the National Academy of Sciences of the United States of America (2019)
LPS-responsive beige-like anchor (LRBA) protein deficiency in humans causes immune dysregulation resulting in autoimmunity, inflammatory bowel disease (IBD), hypogammaglobulinemia, regulatory T (Treg) cell defects, and B cell functional defects, but the cellular and molecular mechanisms responsible are incompletely understood. In an ongoing forward genetic screen for N-ethyl-N-nitrosourea (ENU)-induced mutations that increase susceptibility to dextran sodium sulfate (DSS)-induced colitis in mice, we identified two nonsense mutations in Lrba Although Treg cells have been a main focus in LRBA research to date, we found that dendritic cells (DCs) contribute significantly to DSS-induced intestinal inflammation in LRBA-deficient mice. Lrba -/- DCs exhibited excessive IRF3/7- and PI3K/mTORC1-dependent signaling and type I IFN production in response to the stimulation of the Toll-like receptors (TLRs) 3, TLR7, and TLR9. Substantial reductions in cytokine expression and sensitivity to DSS in LRBA-deficient mice were caused by knockout of Unc93b1, a chaperone necessary for trafficking of TLR3, TLR7, and TLR9 to endosomes. Our data support a function for LRBA in limiting endosomal TLR signaling and consequent intestinal inflammation.
Keyphrases
- toll like receptor
- inflammatory response
- immune response
- dendritic cells
- nuclear factor
- oxidative stress
- high glucose
- induced apoptosis
- drug induced
- signaling pathway
- type diabetes
- diabetic rats
- gene expression
- genome wide
- metabolic syndrome
- machine learning
- electronic health record
- skeletal muscle
- ionic liquid
- cell cycle arrest
- cell death
- heat shock protein
- mesenchymal stem cells
- replacement therapy